New Jersey, NJ (SBWIRE) 02/12/2019 An Artificial heart is device that replace original heart and it perform like original heart. It can be consider as prosthetic device fixed into the body to substitute the organic mammalian heart. Person can live with artificial heart from a few weeks to more than one year. Risk associated with treatment for artificial heart implementation because it can lead to bleed and infection.
The "Global Artificial Heart Market Analysis to 2024" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global artificial heart market with detailed market segmentation by system and geography. The global artificial heart market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the artificial heart market.
Get Sample Copy of Artificial Heart Report: https://www.advancemarketanalytics.com/sample-report/20798-globalartificial-heart-market
Major Players in Artificial Heart Market,
SynCardia Systems (United States) , BiVACOR (United States) , CARMAT (France), Abbott (United States), Cleveland Heart (United States), AbioMed (United States), Jarvik Heart (United States), Cirtec Medical Systems (United States) , Thoratec Corporation (United States) , Boston Scientific Corporation (United States) and Braile Biomedica (Brazil) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Colibri Heart Valve LLC (United States), Cryolife Inc. (United States), Edwards Lifesciences Corporation (United States), Heart Leaflet Technology (United States), Jenavalve Technology Inc. (Germany) and Leman Cardiovascular (Switzerland).
Several concerns inhibit the commercialization of artificial hearts. The key factor is limited durability and longevity marred by faults, either in membrane or power source. Nevertheless, constant advances being made in design and functionality will expand the therapeutic potential of artificial hearts. Growing number of clinical trials to evaluate the role of total artificial heart as destination therapy in patients who have life-threatening biventricular heart failure is likely to augur well for the expansion of the market.
The global artificial heart market is segmented on the basis of system and geography. Based on system, the market is segmented as, artificial heart, power supply and others. The artificial heart is further classified as, Ventricular Assist Device (VAD) and total artificial heart. The power supply is categorized as, internal battery and external battery.
The market study is being classified by Type (Ventricular Assist Device (VAD) and Total Artificial Heart) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America) , Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific) , Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe) , MEA (Middle East, Africa) , North America (United States, Canada, Mexico).
For Early Buyers | Up to 20% Discount on This Premium Report: https://www.advancemarketanalytics.com/request-discount/20798-globalartificial-heart-market
The Global Artificial Heart Market in terms of investment potential in various segments of the market and illustrate the feasibility of explaining the feasibility of a new project to be successful in the near future. The core segmentation of the global market is based on product types, SMEs and large corporations. The report also collects data for each major player in the market based on current company profiles, gross margins, sales prices, sales revenue, sales volume, photos, product specifications and up-to-date contact information.
Table of Content
1. Market Overview
1.2. Scope/Objective of the Study
1.2.1. Research Objective
2. Executive Summary
3. Market Dynamics
3.2. Market Drivers
3.2.1. Rising Mortality Ratio Due To Cardiovascular Diseases
3.2.2. Unhealthy Lifestyle
3.2.3. Undesirable Atmospheric Conditions
3.3. Market Challenges
3.3.1. Need of Skilled Cardiac Specialist
3.3.2. Threat of Substitution by using Alternative Methods
3.4. Market Trends
3.4.1. Increasing Awareness about New Technological Innovations
3.4.2. Government Initiation towards Providing Funds for Treatment of Heart Dieses
4. Market Factor Analysis
4.1. Porters Five Forces
4.2. Supply/Value Chain
4.3. PESTEL analysis
4.4. Market Entropy
4.5. Patent/Trademark Analysis
5. Global Artificial Heart, by Type, End User and Region (value, volume and price) (2013-2018)
Get More Information: https://www.advancemarketanalytics.com/enquiry-before-buy/20798-globalartificial-heart-market
For more information on this press release visit: http://www.sbwire.com/press-releases/artificial-heart-market-witness-highest-growth-in-near-future-leading-key-players-syncardia-systems-bivacor-carmat-abbott-cleveland-heart-abiomed-1144511.htm
Media Relations Contact
AMA Research & Media LLP
Email: Click to Email Nidhi bhawsar